Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus
- 25 August 1999
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 12, S67-S71
- https://doi.org/10.1016/s0924-8579(98)00075-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR).Journal of Antimicrobial Chemotherapy, 1998
- Epidemic methicillin-resistant Staphylococcus aureus: Controlling the spread outside hospitalJournal of Hospital Infection, 1995
- Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1993
- A multicentre, open, clinical trial of a new intravenous formulation of fusidic acid in severe staphylococcal infectionsJournal of Antimicrobial Chemotherapy, 1990
- WORLD-WIDE ANTIBIOTIC RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1989
- Teicoplanin in infections caused by methicillin-resistant staphylococciJournal of Antimicrobial Chemotherapy, 1988
- In vitro and in vivo Activity of Coumermycin and Other Antibacterial Agents against Methicillin-Resistant Strains of Staphylococcus aureusChemotherapy, 1986
- Methicillin resistance in Staphylococcus aureusThe Medical Journal of Australia, 1982
- METHICILLIN-RESISTANT STAPHYLOCOCCIThe Lancet, 1968
- METHICILLIN-RESISTANT STAPHYLOCOCCIThe Lancet, 1968